In a small study of patients with locally advanced pancreatic cancer increased plasma YKL-40, compared to pre-treatment levels, four to six weeks after the end of radiochemotherapy, was associated with short overall survival [57]. The gene discussed is CHI3L1; the disease is familial pancreatic carcinoma.